177 related articles for article (PubMed ID: 31869410)
1. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.
Saygin C; Kishtagari A; Cassaday RD; Reizine N; Yurkiewicz I; Liedtke M; Stock W; Larson RA; Levine RL; Tallman MS; Park JH; Kerr C; Przychodzen B; Sekeres MA; Kalaycio ME; Carraway HE; Hamilton BK; Sobecks R; Gerds A; Mukherjee S; Nazha A; Maciejewski JP; Advani AS
Blood Adv; 2019 Dec; 3(24):4228-4237. PubMed ID: 31869410
[TBL] [Abstract][Full Text] [Related]
2. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?
Tang G; Zuo Z; Thomas DA; Lin P; Liu D; Hu Y; Kantarjian HM; Bueso-Ramos C; Medeiros LJ; Wang SA
Haematologica; 2012 Jun; 97(6):919-25. PubMed ID: 22207681
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to
Aldoss I; Stiller T; Tsai NC; Song JY; Cao T; Bandara NA; Salhotra A; Khaled S; Aribi A; Al Malki MM; Mei M; Ali H; Spielberger R; O'Donnell M; Snyder D; Slavin T; Nakamura R; Stein AS; Forman SJ; Marcucci G; Pullarkat V
Haematologica; 2018 Oct; 103(10):1662-1668. PubMed ID: 29903756
[TBL] [Abstract][Full Text] [Related]
4. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Brunet S; Bergua J; Tormo M; García-Boyero R; Sarrà J; Del Potro E; Grande C; Barba P; Bernal T; Amigo ML; Grau J; Cervera J; Feliu E;
Leuk Lymphoma; 2017 Jan; 58(1):145-152. PubMed ID: 27122129
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation.
Vasudevan Nampoothiri R; Law AD; Lam W; Chen C; Al-Shaibani Z; Loach D; Michelis FV; Kim DDH; Mattsson J; Kumar R; Lipton JH; Viswabandya A
Eur J Haematol; 2020 Jul; 105(1):24-29. PubMed ID: 32115767
[TBL] [Abstract][Full Text] [Related]
6. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia as a second malignant neoplasm in a child with medulloblastoma.
Cağlar K; Unal S; Cetinkaya A; Gümrük F; Yetgin S
Pediatr Hematol Oncol; 2003; 20(7):535-7. PubMed ID: 12959858
[TBL] [Abstract][Full Text] [Related]
8. Philadelphia chromosome as a recurrent event among therapy-related acute leukemia.
Aldoss I; Stiller T; Song J; Al Malki M; Ali H; Salhotra A; Aribi A; Khaled S; Gaytan P; Murata-Collins J; Palmer J; Snyder D; O'Donnell M; Nakamura R; Stein AS; Forman SJ; Marcucci G; Pullarkat V
Am J Hematol; 2017 Feb; 92(2):E18-E19. PubMed ID: 27862221
[No Abstract] [Full Text] [Related]
9. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group.
Pagano L; Pulsoni A; Mele L; Tosti ME; Cerri R; Visani G; Melillo L; Candoni A; Clavio M; Nosari A; Petti MC; Martino B; Mele A; Levis A; Allione B; Almici C; Equitani F; Leone G; Mandelli F;
Ann Oncol; 2001 Feb; 12(2):203-7. PubMed ID: 11300325
[TBL] [Abstract][Full Text] [Related]
11. Hidden FLT3-D835Y clone in FLT3-ITD-positive acute myeloid leukemia that evolved into very late relapse with T-lymphoblastic leukemia.
Katagiri S; Umezu T; Azuma K; Asano M; Akahane D; Makishima H; Yoshida K; Watatani Y; Chiba K; Miyano S; Ogawa S; Ohyashiki JH; Ohyashiki K
Leuk Lymphoma; 2018 Jun; 59(6):1490-1493. PubMed ID: 28972800
[No Abstract] [Full Text] [Related]
12. Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy.
Kelleher N; Gallardo D; González-Campos J; Hernández-Rivas JM; Montesinos P; Sarrá J; Gil C; Barba P; Guàrdia R; Brunet S; Bernal T; Martínez MP; Abella E; Bermúdez A; Sánchez-Delgado M; Antònia C; Gayoso J; Calbacho M; Ribera JM;
Leuk Lymphoma; 2016; 57(1):86-91. PubMed ID: 25860236
[TBL] [Abstract][Full Text] [Related]
13. Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.
Piskunova IS; Obukhova TN; Parovichnikova EN; Kulikov SM; Troitskaya VV; Gavrilina OA; Savchenko VG
Ter Arkh; 2018 Aug; 90(7):30-37. PubMed ID: 30701920
[TBL] [Abstract][Full Text] [Related]
14. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
[TBL] [Abstract][Full Text] [Related]
15. Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.
Schmiegelow K; Levinsen MF; Attarbaschi A; Baruchel A; Devidas M; Escherich G; Gibson B; Heydrich C; Horibe K; Ishida Y; Liang DC; Locatelli F; Michel G; Pieters R; Piette C; Pui CH; Raimondi S; Silverman L; Stanulla M; Stark B; Winick N; Valsecchi MG
J Clin Oncol; 2013 Jul; 31(19):2469-76. PubMed ID: 23690411
[TBL] [Abstract][Full Text] [Related]
16. Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma.
Aldoss I; Capelletti M; Park J; Pistofidis RS; Pillai R; Stiller T; Sanchez JF; Forman SJ; Ghobrial IM; Krishnan A
Leukemia; 2019 Jan; 33(1):266-270. PubMed ID: 30026571
[TBL] [Abstract][Full Text] [Related]
17. T-cell acute lymphoblastic leukemia as a secondary leukemia after a 3-year remission of acute myelocytic leukemia.
Tsuboi K; Komatsu H; Miwa H; Iida S; Banno S; Wakita A; Nitta M; Ueda R
Int J Hematol; 2003 Jun; 77(5):518-21. PubMed ID: 12841392
[TBL] [Abstract][Full Text] [Related]
18. Three patients with multiple myeloma developing secondary lymphoblastic leukemia: case reports and review of the literature.
Junxun L; Junru L; Meilan C; Chujia L; Shaoqian C; Jieyu Z; Zhuangjian Y; Fan Z; Juan O; Jing C; Juan L
Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26166219
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia.
Short NJ; Kantarjian HM; Jabbour EJ; O'Brien SM; Faderl S; Burger JA; Garris R; Qiao W; Huang X; Jain N; Konopleva M; Kadia TM; Daver N; Borthakur G; Cortes JE; Ravandi F
Am J Hematol; 2016 Jun; 91(4):385-9. PubMed ID: 26800008
[TBL] [Abstract][Full Text] [Related]
20. Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance.
Rosenberg AS; Brunson A; Paulus JK; Tuscano J; Wun T; Keegan THM; Jonas BA
Blood Cancer J; 2017 Sep; 7(9):e605. PubMed ID: 28885611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
